NCT02123823 2025-07-15BI 836845 in Estrogen Receptor Positive Metastatic Breast CancerBoehringer IngelheimPhase 1 Completed164 enrolled 21 charts
NCT01938846 2019-01-04BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid TumorsBoehringer IngelheimPhase 1 Completed90 enrolled 22 charts